Spread the risk of antibiotic research

摘要

There are commercial as well as scientific barriers to seeking out new antibiotics (Nature 485,439-440; 2012). These discourage the pharmaceutical industry from investing in further research and clinical development, particularly as current antibiotics are cheap, usually work satisfactorily and generate profits for their manufacturers and distributors.